ArticleACS applied materials & interfaces2026
Tunable Lipid Coatings Enable Cytoplasmic siRNA Delivery by DNA Origami.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA origami nanostructures (DONs) offer precise architectural control for small RNA delivery, but their performance is limited by their susceptibility to nuclease degradation, weak cellular uptake, and inefficient endosomal escape. Here, we introduce an electrostatic lipid-coating strategy that introduces membrane-like properties to DONs while maintaining their structural integrity. By coincubating folded DONs with liposomes composed of a defined mixture of zwitterionic and cationic lipids, we identify a formulation window that yields colloidally stable, monodisperse lipid-coated DONs (LCDs). Systematic variation of the zwitterionic-to-cationic lipid ratio revealed that the fraction of cationic lipids strongly regulates the rate and extent of cellular uptake, with the 50 mol % cationic lipid content emerging as the most effective formulation. LCDs exhibited faster and more extensive cellular internalization and reduced early endosomal retention compared with PEG-coated DONs. The 50 mol % cationic formulation enabled efficient siRNA silencing comparable to benchmark lipid nanoparticles, underscoring the importance of rapid uptake and early endosomal escape for functional delivery while maintaining high cell viability. These findings establish an approach for integrating lipid functionalities onto DONs to improve cytoplasmic delivery while preserving full design flexibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.